Data from animal models and postmortem studies show that increased levels of orexin in the cerebrospinal fluid are associated with disrupted sleep patterns and worsening cognitive function in individuals with Alzheimer’s disease, especially in cases of mild cognitive impairment related to the condition [87,88,89]. This evidence concerns the gene HCRT and Alzheimer disease.